Home › Alzheimer's Disease › Florida › St. Petersburg
Alzheimer's Disease clinical trials in St. Petersburg, FL
4 studies for Alzheimer's Disease are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
RecruitingPhase 1Healthy volunteers welcome
- Local Institution - 0003, Bradenton · 20 mi away
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
RecruitingPhase 1/2
- Key Clinical Research LLC /ID# 277800, Bradenton · 20 mi away
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
RecruitingPhase 3
- Key Clinical Research, Bradenton · 20 mi away
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- Bradenton Research Center, Inc., Bradenton · 20 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- The Villages, FL15 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Burkitt Lymphoma6 studies
- Ovarian Cancer6 studies
- Type 2 Diabetes5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.